Periodontitis - Pipeline Review, H2 2017

SKU ID : GMD-11218077 | Publishing Date : 22-Aug-2017 | No. of pages : 42

Detailed TOC of Periodontitis - Pipeline Review, H2 2017

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Periodontitis - Overview
Periodontitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Periodontitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Periodontitis - Companies Involved in Therapeutics Development
CSL Ltd
Ensol Biosciences Inc
Geistlich Pharma AG
Periodontitis - Drug Profiles
AMY-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drug to Antagonize C5aR for Periodontitis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Fusion Protein to Activate Del-1 for Multiple Sclerosis and Periodontitis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GM-0111 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Hesed-3000 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PODCRC-OHS - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
R-10001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit MMP and Cytokine for Immunology, Respiratory and Musculoskeletal Disorders - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Periodontitis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ST-266 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
taurolidine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Periodontitis - Dormant Projects
Periodontitis - Discontinued Products
Periodontitis - Product Development Milestones
Featured News & Press Releases
Jun 15, 2016: Noveome Initiates Phase 2 Clinical Trial of ST266 to Treat Patients with Periodontitis
Mar 07, 2016: Penn Team Reverses Signs of Naturally Occurring Chronic Periodontitis
May 20, 2014: Penn Team Identifies Promising New Target for Gum Disease Treatment
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Figures, Tables and Charts Available in Periodontitis - Pipeline Review, H2 2017

List of Tables
Number of Products under Development for Periodontitis, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Products under Development by Companies, H2 2017
Products under Development by Universities/Institutes, H2 2017
Number of Products by Stage and Target, H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Periodontitis - Pipeline by CSL Ltd, H2 2017
Periodontitis - Pipeline by Ensol Biosciences Inc, H2 2017
Periodontitis - Pipeline by Geistlich Pharma AG, H2 2017
Periodontitis - Dormant Projects, H2 2017
Periodontitis - Discontinued Products, H2 2017